CoChat

Pharmacological Treatment of Obesity in Older Adults

Open access
Žižka, Ondřej, Haluzík, Martin, Jude, Edward B. · 2024 · Drugs & Aging

The DOI matches its Crossref record; 77 of the 79 references it cites were found in a registry or an index.

Abstract

Obesity is a complex health issue with growing prevalence worldwide. It is also becoming more prevalent in the population of older adults (i.e., 65 years of age and older), affecting frequency and severity as well as other comorbidities, quality of life and consequently, life expectancy. In this article we review currently available data on pharmacotherapy of obesity in the population of older adults and its role in obesity management. Even though there is growing evidence, in particular in the general population, of favourable efficacy and safety profiles of glucagon-like peptide-1 (GLP-1) receptor agonists liraglutide and semaglutide, and recently dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonist tirzepatide, concise guidelines for older adults are not available to this day. We further discuss specific approaches to frequently represented phenotype of obesity in older adults, in particular sarcopenic obesity and rationale when to treat and how. In older adults with obesity there is a need for more drug trials focusing not only on weight loss, but also on geriatric endpoints including muscle mass preservation, bone quality and favourable fat distribution changes to get enough data for evidence-based recommendation on obesity treatment in this growing sub-population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40266-024-01150-9

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Sarcopenia definition. (Based on criteria from: Sarcopenia: revised European consensus on definition and diagnosis [16].)
Fig. 1 Sarcopenia definition. (Based on criteria from: Sarcopenia: revised European consensus on definition and diagnosis [16].)CC BY · PubMed Central
Fig. 2 Lifestyle interventions for treatment of obesity in older adults
Fig. 2 Lifestyle interventions for treatment of obesity in older adultsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Research works printed but not linked: 2

  1. Warren MCL, Trachtenbarg D, Nayak G, Wijayasinghe N, Cariou B. Efficacy and safety of once-weekly semaglutide in elderly subjects with type 2 diabetes: post hoc analysis of SUSTAIN 1–5 trials. Diabetologia. 2017;60(Suppl 1):1–608.
  2. Huecker MR, Smiley A, Saadabadi A. Bupropion. Treasure Island: StatPearls; 2024.

Cited by

See all 23

Metadata

Authors
Žižka, O., Haluzík, M., & Jude, E. B.
Affiliations
  • Charles University (CZ)
  • Tameside Hospital (GB)
Corresponding author
Jude, Edward B.
Venue
Drugs & Aging
Published
2024-11
Volume
41
Issue
11
Pages
881-896
ISSN
  • 1170-229X (ISSN-L)
  • 1179-1969
OpenAlex
W4404195924
Cited by
23
References
79
Citations by year
2026: 11 · 2025: 12
FWCI
6.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Drugs & Aging (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords
obesity, older adults, pharmacotherapy, GLP-1 receptor agonists, liraglutide, semaglutide, tirzepatide, GIP/GLP-1 receptor agonist, sarcopenic obesity, weight loss, muscle mass preservation, bone quality, body fat distribution, drug safety
MeSH terms
Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Aged, Humans, Obesity, Anti-Obesity Agents, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacological Treatment of Obesity in Older Adults. https://app.cochat.ai/papers/10.1007/s40266-024-01150-9
The paper
Žižka, O., Haluzík, M., & Jude, E. B. (2024). Pharmacological Treatment of Obesity in Older Adults. Drugs & Aging. https://doi.org/10.1007/s40266-024-01150-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.